RankingsPricing
  1. US-listed companies
  2. MoonLake Immunotherapeutics
  3. Raw

MoonLake ImmunotherapeuticsMLTX

Market cap
$984.88M
P/E ratio
SummaryFinancials
Back to summarized table
Dec 31,
2020		Dec 31,
2021		Dec 31,
2022		Dec 31,
2023		Dec 31,
2024
Research and development--4232113
General and administrative-5232230
Total operating expenses--6554143
Operating loss-105,755-4,570,345-65,061,417-54,123,096-143,091,082
Other income, net---1022
Loss before income tax---64,469,685-43,984,729-120,962,201
Income tax expense--36,36694,388282,199
Net loss---64,506,051-44,079,117-121
Of which: net loss attributable to controlling interests shareholders-90,838-4,542,654-49,973,249-36,007,260-118,935,517
Net Income (Loss) Attributable to Noncontrolling Interest--4,542,654-14,532,802-8,071,857-2,308,883
Net unrealized gain on marketable securities and short-term investments--390,75323
Actuarial income (loss) on employee benefit plans--269,893-336,579-87,278
Other comprehensive income--660,64623
Comprehensive loss---63,845,405-42,085,595-118,645,458
Comprehensive loss attributable to controlling interests shareholders---49,437,461-34,511,723-116,383,147
Comprehensive loss attributable to noncontrolling interests---14,407,944-7,573,872-2,262,311
Earnings Per Share, Diluted---1.7-0.73-1.89
Earnings Per Share, Basic---1.7-0.73-1.89